Table 3.
Method |
VND |
α |
Pancreatic BPND |
||||||
---|---|---|---|---|---|---|---|---|---|
HC | T1DM | HC | T1DM | All subjects | HC | T1DM | P value | % difference | |
1. VT(+,spleen) | 27 (8) | 31 (17) | 5.0 (27) | 2.2 (55) | 0.01 | 56 | |||
2. VT(+,renal cortex) | 23 (l1) | 21 (18) | 6.2 (32) | 3.8 (51) | 0.10 | 38 | |||
3. VT(−,pancreas) | 24 (14) | 18 (26) | 6.3 (50) | 4.3 (40) | 0.29 | 31 | |||
4. VT(+,spleen)/αspleen | 62 (8)* | 70 (17)* | 0.37 (25) | 0.54 (40) | 0.44 (38) | 1.6 (36)* | 0.40 (132)* | 0.01 | 75 |
5. VT(+,renal cortex)/αrenal | 46 (11)* | 41 (18)* | 0.45 (21) | 0.60 (27) | 0.51 (28) | 2.7 (38)* | 1.5 (68)* | 0.10 | 45 |
Vnd values and α ratios were derived from the MA1 VT values using three methods. See text for details. Data are expressed as mean (COV%). Group differences in pancreatic BPnd were compared using t test
αspleen and αrenal from all subjects were used to calculate Vnd and BPnd